1. Home
  2. KMDA vs EHAB Comparison

KMDA vs EHAB Comparison

Compare KMDA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.44

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Logo Enhabit Inc.

EHAB

Enhabit Inc.

HOLD

Current Price

$13.93

Market Cap

692.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMDA
EHAB
Founded
1990
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
488.6M
692.9M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KMDA
EHAB
Price
$8.44
$13.93
Analyst Decision
Strong Buy
Hold
Analyst Count
2
5
Target Price
$14.00
$13.84
AVG Volume (30 Days)
61.1K
1.0M
Earning Date
05-13-2026
05-06-2026
Dividend Yield
2.96%
N/A
EPS Growth
N/A
97.11
EPS
N/A
N/A
Revenue
N/A
$1,060,000,000.00
Revenue This Year
$13.94
$6.42
Revenue Next Year
$9.84
$4.88
P/E Ratio
$24.59
N/A
Revenue Growth
N/A
2.44
52 Week Low
$6.29
$6.47
52 Week High
$9.35
$14.22

Technical Indicators

Market Signals
Indicator
KMDA
EHAB
Relative Strength Index (RSI) 48.73 70.40
Support Level $8.38 $10.79
Resistance Level $8.88 $14.22
Average True Range (ATR) 0.19 0.09
MACD 0.02 -0.06
Stochastic Oscillator 72.22 50.00

Price Performance

Historical Comparison
KMDA
EHAB

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: